Artículos por temáticas

From Adipose to Action: Reprogramming Stem Cells for Functional Neural Progenitors for Neural Regenerative Therapy

Peng J, Zhang Z, Li M, Yung KKL, Cheung KH.

Int J Mol Sci. 2025 Jul 9;26(14):6599. doi: 10.3390/ijms26146599.

Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease

Bendetowicz D, Planche V, Bezard E, Dehay B, Meissner WG.

J Parkinsons Dis. 2025 Aug;15(5):944-952. doi: 10.1177/1877718X241313443. Epub 2025 Feb 4.

CDS-PD: A Novel Clinical Decision Support Platform for Parkinson's Disease

Gupta DK, Golnari P, Prantzalos K, Zurlo I, Iyer V, Lobb BM, Zweber C, Bulusu M, Clarke D, Boyd JT, Tatsuoka C, Hiller AL, Sahoo SS.

medRxiv [Preprint]. 2025 Jul 25:2025.07.24.25331875. doi: 10.1101/2025.07.24.25331875.

GLP-1 receptor agonists in Parkinson's disease: an updated comprehensive systematic review with meta-analysis

Helal MM, AbouShawareb H, Abbas OH, Haddad R, Zain Y, Osman ASA, Hassan AK.

Diabetol Metab Syndr. 2025 Aug 23;17(1):352. doi: 10.1186/s13098-025-01888-1.

The effects of transcranial magnetic stimulation in motor symptoms of Parkinson's disease: an overview of systematic reviews with meta-analysis

Conte D, Roman A, Beorchia Y, Pinzini C, Castriotta L, Valente M.

Neurol Sci. 2025 Aug;46(8):3405-3418. doi: 10.1007/s10072-025-08189-5. Epub 2025 Apr 16.

Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson's disease

Liu YD, Li HF, Zhai YX, Shen YX, Yang J, He LM, Shen T.

Front Neurol. 2025 Jul 3;16:1598974. doi: 10.3389/fneur.2025.1598974. eCollection 2025.

Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson's Disease

Lange LM, Fang ZH, Screven L, Tan AH, Alcalay RN, Amouri R, Bovenzi R, Fenn M, Frost JLI, Jankovic J, Jasaityte S, Jaunmuktane Z, Jeon B, Keller Sarmiento IJ, Krüger R, Kuhlenbäumer G, Lin CH, Pavelka

medRxiv [Preprint]. 2025 Jul 11:2025.07.10.25330831. doi: 10.1101/2025.07.10.25330831.

Therapeutic Targeting of Autosomal Parkinson's Disease by Modulation of Leucine-Rich Repeat Kinase 2 (LRRK2) Protein

Hyderi Z, Farhana M S, Singh TP, Ravi AV.

Brain Res. 2025 Aug 1;1860:149674. doi: 10.1016/j.brainres.2025.149674. Epub 2025 May 8.

Botulinum Toxin for the Treatment of Tremors

Bellows S, Jankovic J.

Toxins (Basel). 2025 Aug 11;17(8):401. doi: 10.3390/toxins17080401.

Gastrointestinal Manifestations in Parkinson's Disease Using a Validated Arabic Version of Gastrointestinal Dysfunction Scale: A Multicenter Study

Shalash AS, Badr MY, Salah Y, Elgamal S, Elaidy SA, Elhamrawy EA, Abdel-Tawab H, Hamid E, El-Seidy EA, Dawood NL; Egyptian Parkinson Research Group.

Mov Disord Clin Pract. 2025 Jul;12(7):947-956. doi: 10.1002/mdc3.70005. Epub 2025 Mar 15.

Animal Models for the Study of Neurological Diseases and Their Link to Sleep

Rubio C, González-Sánchez E, Lee Á, Ponce-Juárez A, Serrano-García N, Rubio-Osornio M.

Biomedicines. 2025 Aug 18;13(8):2005. doi: 10.3390/biomedicines13082005.

The Search for Disease Modification in Parkinson's Disease-A Review of the Literature

Barber D, Wijeratne T, Singh L, Barnham K, Masters CL.

Life (Basel). 2025 Jul 23;15(8):1169. doi: 10.3390/life15081169.

Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson's disease

Ramadan ME, Mostafa TM, Ghali AA, El-Afify DR.

Inflammopharmacology. 2025 Jul;33(7):3897-3908. doi: 10.1007/s10787-025-01752-8. Epub 2025 May 28.

Selected risk factors for motor fluctuations in Parkinson's disease: a meta-analysis

Huang Q, Weng H, Weng X, Zhao ZH.

Clin Neurol Neurosurg. 2025 Aug;255:108921. doi: 10.1016/j.clineuro.2025.108921. Epub 2025 May 24.

Music-based intervention as a new therapeutic treatment for executive dysfunction in Parkinson's disease

Wang Z, Liu Y, Li C, Qin K, Yu X, Xie A.

Neuroscience. 2025 Aug 6;580:306-314. doi: 10.1016/j.neuroscience.2025.06.057. Epub 2025 Jun 28.